LCT In The News

12 January 2022

Why putting animal organs inside people could be the future of medicine

Surgeon Christiaan Barnard performed the world’s first successful human heart transplant in 1967. Now doctors have performed the first successful transplantation of a pig’s heart into a human. Experts suggest genetically modified pigs could even produce blood suitable for human transfusion, or dopamine for Parkinson’s sufferers. 

20 January 2022

Australian - "Pigs and us"

The transplantation of a pig heart to a heart disease sufferer in the United States was a groundbreaking event, LCT's Professor Bernie Tuch told the Australian. The use of pig cells for the treatment of chronic disease could extend to disease...

25 January 2022

"Why pigs on this remote Auckland island may be the key to treating Parkinson’s disease" - The Sentiment

"Of all the places in the world where you thought a cure for Parkinson’s disease might be found, the remote sub-Antarctic Auckland Islands might not have been your first choice but that’s exactly where biotech company Living Cell Technologies (ASX: LCT) will obtain tissue for their clinical trials," reports The Sentiment.

1 February 2022

NZ pigs possible key to treating Parkinson's

31 March 2022

Biotech Dispatch - "NTCELL to be produced in Australia under UTS research agreement"

NTCELL will be produced in Australia under a research agreement with the University of Technology Sydney and the Australian Foundation for Diabetes Research, reports Biotech Dispatch.

23 May 2022

Kalkine Media - "Major Breakthrough! Living Cell Technologies (ASX:LCT) to use AI in research for Parkinson’s"

LCT is set to apply AI in NTCELL research to augment the quality of its third clinical trial in Parkinson’s disease, reports Kalkine Media.